Correction to: Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis
Crossref DOI link: https://doi.org/10.1007/s40263-018-0595-4
Published Online: 2018-12-20
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Papadopoulos, Dimitrios
Mitsikostas, Dimos-Dimitrios D. http://orcid.org/0000-0002-4691-3388
Text and Data Mining valid from 2018-12-20
Article History
First Online: 20 December 2018